Chilakamarri, Priyanka
Finn, Emily B.
Sather, John
Sheth, Kevin N.
Matouk, Charles
Parwani, Vivek
Ulrich, Andrew
Davis, Melissa
Pham, Laura
Chaudhry, Sarwat I.
Venkatesh, Arjun K. http://orcid.org/0000-0002-8248-0567
Funding for this research was provided by:
Agency for Healthcare Research and Quality (P30HS023554)
National Institutes of Health (P30AG021342)
National Center for Advancing Translational Sciences (KL2 TR000140)
Article History
Received: 5 June 2020
Accepted: 18 November 2020
First Online: 5 January 2021
Conflict of interest
: Dr. Sheth reports grants from Novartis, grants from NIH, during the conduct of the study. Dr. Chaudhry reports and Dr. Chaudhry serves as a reviewer for the CVS Caremark State of Connecticut Clinical Program. Dr. Venkatesh reports grants from Agency for Healthcare Research and Quality, grants from NIH/NIA, grants from NIH—National Center for Advancing Translational Science, during the conduct of the study. Dr. Matouk has nothing to disclose. Dr. Chilakamarri, Dr. Finn, Dr. Sather, Dr. Parwani, Dr. Ulrich, Dr. Davis, Dr. Pham, and Dr. Chilakamarri have nothing to disclose.
: This manuscript adheres to ethical guidelines and was approved by the Yale Institutional Review Board.